Sirt6 promotes tumorigenesis and drug resistance of diffuse large B-cell lymphoma by mediating PI3K/Akt signaling

Juan Yang(Ningxia Medical University), Xin Wang(Shandong Provincial Hospital)
Journal of Experimental & Clinical Cancer Research
July 25, 2020
10.1186/s13046-020-01623-w
Cited by 76

Related Papers

Targeting the Wnt/β-catenin signaling pathway in cancer
|Journal of Hematology & Oncology|2020|1.4k
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent
|Journal of Experimental & Clinical Cancer Research|2021|291
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Drug resistance in ovarian cancer: from mechanism to clinical trial
|Molecular Cancer|2024|233